Literature DB >> 1302034

Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.

H A Jaffe1, C Danel, G Longenecker, M Metzger, Y Setoguchi, M A Rosenfeld, T W Gant, S S Thorgeirsson, L D Stratford-Perricaudet, M Perricaudet.   

Abstract

Replication deficient, recombinant adenovirus (Ad) vectors do not require target cell replication for transfer and expression of exogenous genes and thus may be useful for in vivo gene therapy in hepatocytes. In vitro, primary cultures of rat hepatocytes infected with a recombinant Ad containing a human alpha 1-antitrypsin cDNA (Ad-alpha 1AT) synthesized and secreted human alpha 1AT for 4 weeks. In rats, in vivo intraportal administration of a recombinant Ad containing the E. coli lacZ gene, was followed by expression of beta-galactosidase in hepatocytes 3 days after infection. Intraportal infusion of Ad-alpha 1AT produced detectable serum levels of human alpha 1AT for 4 weeks. Thus, targeted gene expression has been achieved in the liver, albeit at low levels, suggesting that adenovirus vectors may be a useful means for in vivo gene therapy in liver disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302034     DOI: 10.1038/ng0892-372

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  86 in total

Review 1.  Gene therapy of hepatic diseases: prospects for the new millennium.

Authors:  K Shetty; G Y Wu; C H Wu
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Authors:  A Recchia; R J Parks; S Lamartina; C Toniatti; L Pieroni; F Palombo; G Ciliberto; F L Graham; R Cortese; N La Monica; S Colloca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Absence of direct delivery for single transmembrane apical proteins or their "Secretory" forms in polarized hepatic cells.

Authors:  M Bastaki; L T Braiterman; D C Johns; Y-H Chen; A L Hubbard
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

4.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.

Authors:  Kazuaki Miyake; Wataru Ogawa; Michihiro Matsumoto; Takehiro Nakamura; Hiroshi Sakaue; Masato Kasuga
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.

Authors:  Raul Alba; Angela C Bradshaw; Lynda Coughlan; Laura Denby; Robert A McDonald; Simon N Waddington; Suzanne M K Buckley; Jenny A Greig; Alan L Parker; Ashley M Miller; Hongjie Wang; Andre Lieber; Nico van Rooijen; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

7.  Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

Authors:  Y Dai; E M Schwarz; D Gu; W W Zhang; N Sarvetnick; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.

Authors:  Yongzhu Jin; Qingyin Zhang; Jie Hao; Xiang Gao; Yinglu Guo; Shusheng Xie
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

9.  A simple technique to establish a long-term adenovirus mediated gene transfer to the heart of newborn mice.

Authors:  Marina Jerebtsova; Xuehai Ye; Patricio E Ray
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2009-06

10.  Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.

Authors:  S D Rettinger; S C Kennedy; X Wu; R L Saylors; D G Hafenrichter; M W Flye; K P Ponder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.